CureVac, once a player in the Covid-19 vaccine race, announced that it plans to reduce costs across the company.
READ MORENeurocrine Biosciences’ newly-debuted campaign acknowledges the frustration that congenital adrenal hyperplasia (CAH) patients, families and endocrinologists often feel.
READ MOREImmunityBio scored an FDA approval for its once-rejected drug combo for bladder cancer, the biotech announced Monday, sending its stock up nearly 25% in premarket trading.
READ MOREThermo Fisher said it will be a “long-term beneficiary” of biopharma customers localizing their supply chains, given most of its network is based in the US and Europe.
READ MORE